Jolley Asset Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Jolley Asset Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2020$3,871,000
-14.3%
46,955
-1.6%
2.98%
+15.9%
Q4 2019$4,516,000
+2.2%
47,697
-6.2%
2.57%
-10.6%
Q3 2019$4,417,000
-4.9%
50,832
-0.0%
2.87%
-3.7%
Q2 2019$4,643,000
-4.4%
50,853
+0.6%
2.98%
-15.2%
Q1 2019$4,859,000
+13.0%
50,538
+0.8%
3.52%
+6.6%
Q4 2018$4,301,000
+0.3%
50,126
+0.7%
3.30%
+14.7%
Q3 2018$4,287,000
+15.1%
49,756
+0.9%
2.88%
+15.3%
Q2 2018$3,726,000
-5.4%
49,326
+1.2%
2.50%
+4.6%
Q1 2018$3,940,000
-1.0%
48,736
+2.8%
2.39%
-5.8%
Q4 2017$3,981,000
-1.2%
47,421
+1.0%
2.53%
-7.3%
Q3 2017$4,030,000
+1.7%
46,946
-1.1%
2.73%
-1.5%
Q2 2017$3,962,000
+12.5%
47,469
+0.1%
2.78%
+9.7%
Q1 2017$3,522,000
+6.2%
47,424
+4.2%
2.53%
+6.4%
Q4 2016$3,315,000
+1.9%
45,504
+10.5%
2.38%
-9.7%
Q3 2016$3,252,000
-3.0%
41,180
+1.3%
2.63%
-2.4%
Q2 2016$3,353,000
+7.3%
40,643
-5.8%
2.70%
-5.2%
Q1 2016$3,124,000
-0.8%
43,130
+17.9%
2.84%
-5.0%
Q4 2015$3,148,000
-5.0%
36,586
+1.5%
2.99%
-10.9%
Q3 2015$3,315,000
-7.2%
36,061
-0.8%
3.36%
+3.4%
Q2 2015$3,574,000
-2.0%
36,346
-1.7%
3.25%
+7.2%
Q1 2015$3,648,000
+1.4%
36,993
-4.8%
3.03%
+1.7%
Q4 2014$3,599,000
-1.3%
38,838
+0.2%
2.98%
+1.3%
Q3 2014$3,647,000
+1.4%
38,746
-2.5%
2.94%
+11.3%
Q2 2014$3,597,000
+0.3%
39,735
-5.8%
2.64%
-0.9%
Q1 2014$3,585,000
+3.9%
42,165
-1.8%
2.67%
-2.0%
Q4 2013$3,451,000
+3.4%
42,933
-1.3%
2.72%
-2.1%
Q3 2013$3,336,000
+4.2%
43,492
-4.0%
2.78%
+7.2%
Q2 2013$3,203,00045,2972.59%
Other shareholders
NOVARTIS A G shareholders Q4 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders